Phase III Trial of Camrelizumab+Apatinib+Eribulin vs. Physician's Choice Chemotherapy in Advanced Triple-Negative Breast Cancer

Name: Phase III Trial of Camrelizumab+Apatinib+Eribulin vs. Physician's Choice Chemotherapy in Advanced Triple-Negative Breast Cancer
License: Public Domain

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

triple-negative-breast-cancer

breast cancer stage iv, triple -negative breast cancer

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 174872
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.